Alpha Tau Medical Ltd

Alpha Tau Medical Ltd

DRTS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.21B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alpha Tau Medical LtdAlpha Tau Medical Ltd-12.6--210%-0.3
$23.00

Target Price by Analysts

79.3% upsideAlpha Tau Medical Target Price DetailsTarget Price
$0.03

Current Fair Value

99.8% downside

Overvalued by 99.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.21 Billion
Enterprise Value$1.20 Billion
Earnings per Share$-0.53
Beta1.22
Outstanding Shares90,954,000

Return

Return on Equity-210.13%ROE
Return on Assets-68.96%
Return on Invested Capital-40.47%

Valuation & Multiples

P/E Ratio-12.56P/E Ratio
PEG-3.56PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-23.8
Enterprise Value to Net Income-13
Total Debt to Enterprise0.01
Debt to Equity0.34Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 18, 2026
EPS Estimate
$-0.13
Consensus analyst estimate
Revenue Estimate
$144,500
Consensus analyst estimate

Next Earnings Call

Expected Date
November 19, 2026
EPS Estimate
$-0.14
Consensus analyst estimate
Revenue Estimate
$243,250
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 39.94%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.02%▼ 8.72%
Total Invested$336,989▼ 99.66%
Investors Holding4▼ 76.00%

About Alpha Tau Medical Ltd

2 employees

Alpha Tau Medical Insider Information FAQ

Stockcircle tracks 4 top investors with a current 13F position in Alpha Tau Medical. Notable holders include ARK Invest. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions and 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 9 open-market insider sales for Alpha Tau Medical in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.